Münchener Rück AG

TickerMUV2.XETRA
Current Price –
Münchener Rück AG – stock chart

5-year stock timeline

2026 Oct–Nov (Q3 2026 preliminary / guidance raise)

Munich Re reported a preliminary Q3 2026 net profit of approximately €1.7bn and raised full-year net profit guidance for 2026 from €6.3bn to €6.6bn (management statement 23 Oct 2026; final Q3 results scheduled for 12 Nov 2026). The market reaction reflected continued confidence in Munich Re's diversified earnings mix and strong investment returns. Investors viewed the raise as confirmation that low major losses and favourable investment markets had materially improved near-term earnings visibility. The tone shifted further toward a "high-quality earnings" story with capital flexibility for balance-sheet actions.

Nine-month net result through Q3: €5.7bn [3]

2026 H1 (reported Aug 2026; strong H1 performance)

H1 2026 results showed a net result of €3,925m (H1 2025: €3,178m) with EPS of €30.89 (H1 2025: €24.26). Return on equity reached 23.0% and the Solvency II ratio stood at approximately 304% (Q2 2026 IR handout). Management reiterated the full-year target (initially ~€6.3bn) while trimming revenue guidance for reinsurance and group insurance.

Investor perception moved to "outperformance driven by both underwriting discipline and unusually strong investment returns." The low major-loss environment in P&C reinsurance and high equity returns reinforced a growth and quality narrative and supported expectations for shareholder returns through buybacks and dividends. Analysts noted revenue guidance trims reflecting deliberate portfolio pruning and disciplined underwriting at July renewals.

P&C reinsurance combined ratio H1: 67.9% [5][14]

2026 Q2 (preliminary July / Q2 release July–Aug 2026)

Q2 2026 net result reached approximately €2.2bn, driven by low major losses and strong investment income (final Q2 release confirmed results in early August). Management lowered reinsurance revenue guidance by approximately €2bn to €38bn while maintaining net result ambition.

Investors credited disciplined underwriting (volumes reduced at renewals) and the investment cycle (strong equity markets) for boosting earnings. Market commentary emphasised resilience and the company's ability to preserve underwriting discipline while still delivering earnings. Some analysts warned of potential reversion if major losses or market volatility return.

P&C reinsurance combined ratio Q2: 68.9% [11][5][12]

2025 full year and early 2026 capital actions (Feb–Dec 2025 / early 2026)

For FY 2024 (reported Feb 2025) Munich Re posted a net result of €5,671m (outperforming the original target). In 2025 the company announced an expanded share buyback programme (up to €2bn) to be executed by the 2026 AGM. Ambition 2030 strategic targets continued to be reiterated (ROE >18%, payout >80%, etc.). The annual report 2025 (issued in 2026) included continued focus on diversification and capital strength.

After multiple years of beating targets, investor perception shifted toward expecting consistent capital returns through dividends and buybacks and execution of the Ambition 2030 strategy. The buyback and repeated profit beats supported a "capital-light compounder with shareholder returns" narrative, though some investors cautioned on exposure to catastrophe years and market sensitivity of investment income [15][2].

2024 results and operating metrics (reported Mar 2025)

Munich Re reported a significantly improved result versus 2023, with group profit and higher dividends. The 2024 annual reports (published March 2025) included segment metrics such as gross premiums written, investments, and shareholders' equity.

The company was seen as recovering from earlier pandemic and inflation headwinds, with improving underwriting performance and an investment environment that boosted returns. This supported a transition narrative from cyclical recovery toward structurally stronger returns when combined with disciplined underwriting.

Group gross premiums written 2024: €33,383m; Company shareholders' equity: €13,977m; Company profit for the year: €4,756m; dividend per share: €20.00 [7]

2023 renewals and market repricing (2023)

2023 featured mixed renewal outcomes across reinsurance segments with selective price increases in certain lines after a period of soft pricing earlier in the cycle. Exposure to inflationary claims and natural catastrophe activity kept pressure on reserve reviews. Annual report 2023 and investor materials discussed normalisation of pricing in parts of the market.

Investors saw Munich Re as navigating a hardening cycle in some markets while facing margin pressure from inflation and reserve volatility. Perceptions shifted toward valuation discipline and the importance of underwriting quality rather than top-line growth alone. Munich Re's diversification (life & health, ERGO, specialty) was emphasised as a stabiliser [1].

2022 major-loss environment and reserve developments (2022)

2022 included elevated major-loss events (natural catastrophes globally) and market volatility that pressured reinsurance combined ratios industry-wide. Munich Re disclosed increased major-loss expenditures and reserve adjustments in annual results. The company continued to execute its medium-term strategic targets and capital management plans.

Investor perception during and after 2022 was cautious—recognising Munich Re's strong capital base but mindful that catastrophe years materially affect earnings volatility. The stock was characterised more as a well-capitalised but cyclically sensitive insurer and reinsurer [1].

2021 (pandemic aftermath and strategic repositioning)

In 2021 Munich Re continued to manage pandemic-related effects and accelerated strategic initiatives (digitalisation, portfolio management, focus on profitable growth in specialty and life & health reinsurance). Annual reports and investor communications detailed those shifts.

Investors considered Munich Re to be in transition from pandemic-era disruption toward executing structural improvements—emphasising underwriting discipline and diversification as drivers for medium-term RoE improvement. The stock narrative was mixed: recovery potential tempered by catastrophe and market risk [1].

Key risks and downside factors

Munich Re (Munchener Ruck, MUV2.XETRA, ISIN DE0008430026) stands among the world's largest reinsurers, operating across life and non-life reinsurance, specialty reinsurance, and primary insurance and risk-management services through its ERGO subsidiary. The competitive landscape includes Swiss Re, Hannover Re, SCOR, Berkshire Hathaway's reinsurance operations, Lloyd's market participants, and major Bermuda and US carriers—all contending on capacity, pricing, and capital efficiency. The company faces material exposure to catastrophe losses, underwriting margin compression from rate softening, investment and interest-rate fluctuations, and the shifting regulatory environment under IFRS 17 and Solvency II frameworks.

  • Severe underwriting losses from large catastrophes or pandemics can materially reduce both capital and profitability.
  • Softening rate environments and fierce competition during treaty renewals tend to squeeze underwriting margins while simultaneously dampening premium volumes.
  • Investment losses or sustained periods of low or volatile interest rates can reduce the investment income and surplus capital that support underwriting operations.
  • Regulatory shifts, IFRS 17 implementation, and varying capital requirements across jurisdictions are likely to raise capital costs and narrow the room for product and pricing adjustments.

Competitive landscape

Münchener Rückversicherungs-Gesellschaft (Munich Re, MUV2.XETRA) stands as the world's largest reinsurer, competing within a narrow band of diversified international reinsurers and major insurance groups that operate substantial reinsurance divisions. Its most direct competitive pressure stems from scale peers like Swiss Re and Hannover Re, diversified global insurers such as Allianz and AXA, and well-capitalized actors including Berkshire Hathaway Reinsurance. The business faces material risks from catastrophe losses and reserving accuracy, investment volatility and interest-rate sensitivity, pricing discipline across market cycles, and the shifting landscape of regulation alongside climate-related exposure.

CompanyTicker
Swiss ReSREN.SIX
Hannover RückHNR1.XETRA
Allianz SEALV.XETRA
AXA SACS.PA
Everest Re GroupRE.NYSE
RenaissanceRe HoldingsRNR.NYSE
Arch Capital Group Ltd.ACGL.NYSE

Private competitors

  • Some Lloyd’s syndicates (unlisted)

    A collective of private and market syndicates operating at Lloyd's that provide reinsurance capacity and specialty coverages. They compete with Munich Re across select treaties and specialty lines.

  • Convex Group (private until IPO)

    Specialty insurer and reinsurer operating in wholesale and specialty lines, competing directly with Munich Re across specialty reinsurance and Lloyd's market segments.

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Performance Figures of Münchener Rück AG

in EUR

1M High / Low
602.80 / 537.80
52W High / Low
602.80 / 437.40
5Y High / Low
615.80 / 205.15
1M
+6.70%
3M
+12.94%
6M
+24.35%
1Y
+14.99%
3Y
+72.18%
5Y
+188.00%

Relative Performance vs Benchmarks

PeriodMünchener Rück AG vs DAX vs S&P 500 (SPY)
1M +6.70% +4.99% +11.75%
3M +12.94% +14.47% +17.34%
6M +24.35% +20.94% +25.92%
1Y +14.99% +3.88% +3.60%
3Y +72.18% +10.33% +5.50%
5Y +188.00% +128.74% +121.49%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current11.01.32.257.5
1Y ago11.30.32.222.3
3Y ago10.00.81.9-6.7
5Y ago15.60.61.24.9

Frequently Asked Questions

Where is the Münchener Rück AG stock traded?

The Münchener Rück AG stock trades under the ticker MUV2.XETRA on the XETRA exchange. ISIN: DE0008430026.

What does Münchener Rück AG do?

Münchener Rück AG is a company characterized by the following investment thesis:

What are the key metrics for MUV2.XETRA?

Key metrics for MUV2.XETRA include valuation (P/E 10.9, P/S 1.2, P/B 2.2), profitability (profit margin 11.98%, ROE 20.11%), and growth (revenue –, earnings –). Market capitalization is 73.37B EUR. These metrics give an overview of the company's financial performance and valuation.

How has Münchener Rück AG's stock price performed?

Münchener Rück AG's stock has returned – over 1 year, – over 3 years, and – over 5 years. Performance can vary depending on market conditions and company developments.

How is MUV2.XETRA valued?

MUV2.XETRA has the following valuation metrics: P/E Ratio: 10.9, P/S Ratio: 1.2, P/B Ratio: 2.2. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

What are the key risks when investing in MUV2.XETRA?

Key risks for MUV2.XETRA include: Munich Re (Munchener Ruck, MUV2.XETRA, ISIN DE0008430026) stands among the world's largest reinsurers, operating across life and non-life reinsurance, specialty reinsurance, and primary insurance and risk-management services through its ERGO subsidiary. The competitive landscape includes Swiss Re, Hannover Re, SCOR, Berkshire Hathaway's reinsurance operations, Lloyd's market participants, and major Bermuda and US carriers—all contending on capacity, pricing, and capital efficiency. The company faces material exposure to catastrophe losses, underwriting margin compression from rate softening, investment and interest-rate fluctuations, and the shifting regulatory environment under IFRS 17 and Solvency II frameworks.
  • Severe underwriting losses from large catastrophes or pandemics can materially reduce both capital and profitability.
  • Softening rate environments and fierce competition during treaty renewals tend to squeeze underwriting margins while simultaneously dampening premium volumes.
  • Investment losses or sustained periods of low or volatile interest rates can reduce the investment income and surplus capital that support underwriting operations.
  • Regulatory shifts, IFRS 17 implementation, and varying capital requirements across jurisdictions are likely to raise capital costs and narrow the room for product and pricing adjustments.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Münchener Rück AG?

Münchener Rück AG competes with several listed peers in its sector. Münchener Rückversicherungs-Gesellschaft (Munich Re, MUV2.XETRA) stands as the world's largest reinsurer, competing within a narrow band of diversified international reinsurers and major insurance groups that operate substantial reinsurance divisions. Its most direct competitive pressure stems from scale peers like Swiss Re and Hannover Re, diversified global insurers such as Allianz and AXA, and well-capitalized actors including Berkshire Hathaway Reinsurance. The business faces material risks from catastrophe losses and reserving accuracy, investment volatility and interest-rate sensitivity, pricing discipline across market cycles, and the shifting landscape of regulation alongside climate-related exposure.
  • Swiss Re (SREN.SIX)
  • Hannover Rück (HNR1.XETRA)
  • Allianz SE (ALV.XETRA)
  • AXA SA (CS.PA)
  • Everest Re Group (RE.NYSE)
  • RenaissanceRe Holdings (RNR.NYSE)
  • Arch Capital Group Ltd. (ACGL.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

When does Münchener Rück AG report earnings?

Münchener Rück AG's next earnings report date is February 25, 2027.

Key Metrics

Market Capitalization
73.37B EUR
P/E Ratio
10.94
Analyst Target Price
–

Valuation Metrics

P/S Ratio
1.16
P/B Ratio
2.22

Profitability Metrics

Profit Margin
11.98%
Operating Margin
16.34%
Return on Equity
20.11%
Return on Assets
2.04%

Growth Metrics

Revenue Growth
–
Earnings Growth
–

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
202624.00 EUR4.56%4.24%
202520.00 EUR3.32%
202415.00 EUR3.54%
202311.60 EUR3.43%
202211.00 EUR4.56%
20219.80 EUR3.81%
20209.80 EUR4.44%
20199.25 EUR4.15%
20188.60 EUR4.35%
20178.60 EUR4.54%
20168.25 EUR4.74%
20157.75 EUR4.06%
20147.25 EUR4.36%
20137.00 EUR4.41%
20126.25 EUR5.34%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

68.3%
Beat estimate
30.2%
Miss estimate
+31.19%
Avg surprise when beat
-12.04%
Avg surprise when miss

Reports analyzed: 63

Upcoming earnings report

February 25, 2027
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
Consensus51.62
Range49.20 – 54.98
12 analysts
Est. growth vs prior: -3.11%
Revisions: 7d ↑1 ↓0 · 30d ↑2 ↓5
Next quarter
March 31, 2027
Consensus10.37
Range10.37 – 10.37
1 analysts
Est. growth vs prior: -22.64%
Revisions: 7d ↑0 ↓0 · 30d ↑0 ↓1

Key financial figures

All figures in EUR

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue69.30B69.11B70.46B64.11B63.86B
Operating income (EBIT)8.63B8.71B3.63B10.01B2.41B
Net income6.12B5.68B4.66B3.42B2.93B
Free cash flow1.10B2.83B2.40B-18.32B5.23B
Total assets279.93B286.51B273.79B298.57B312.40B
Equity33.25B32.64B29.65B21.06B30.83B
Net debt1.93B205.00M-3.86B-2.87B-1.98B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon